PRICE T ROWE ASSOCIATES INC /MD/

Position in BCAX — Bicara Therapeutics Inc.

CIK 80255 BALTIMORE, MD

Position in BCAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$27,372,578

+$1,125,605 QoQ

Shares Held

1,376,198

-11.8% QoQ

Ownership

2.09%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 99.9366370246142.ToString("F0")% Shared 0.ToString("F0")% None 0.0633629753858093.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. BCAX ranks #75 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	3,374,955	$2,464,560,888
2	REGN	Regeneron Pharmaceuticals, Inc.	2,177,527	$1,682,444,460
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,760,122	$785,964,877
4	INSM	INSMED Inc	3,092,807	$505,735,799
5	KYMR	Kymera Therapeutics, Inc.	6,060,847	$504,807,946
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,432,748	$474,053,330
7	ASND	Ascendis Pharma A/S	1,530,345	$350,035,811
8	RVMD	Revolution Medicines, Inc.	3,232,213	$314,332,713

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$27,372,578	1,376,198	-11.8%	Shares	Defined	2026-05-15
2025-12-31	$26,246,973	1,559,535	-11.2%	Shares	Sole	2026-02-17
2025-09-30	$27,717,939	1,755,411	-18.4%	Shares	Sole	2025-11-14
2025-06-30	$19,976,379	2,150,310	+19.6%	Shares	Sole	2025-08-14
2025-03-31	$23,428,212	1,798,021	+16.2%	Shares	Sole	2025-05-14
2024-12-31	$26,951,875	1,547,180	+0.5%	Shares	Sole	2025-02-14
2024-09-30	$39,196,648	1,538,934	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.